GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.
$4,346,947
| Recipient | MINISTRY OF DEFENCE UEI U6LDUQKZ2CS8 |
|---|---|
| Award ID | HDTRA124C0008 |
| Award amount | $4,346,947 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Defense — Defense Threat Reduction Agency |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AC32 |
| Start date | Jun 10, 2024 |
| End date | Jun 9, 2026 |
| Place of performance | — |
| Record updated | Jun 6, 2024 |
View the official award record
More awards won by MINISTRY OF DEFENCE
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREAS A AND B
Department of Health and Human Services · $146,300,000 · Jul 15, 2024
CWB KITS & SHIPPING FIXTURE
Department of Defense · $9,139,900 · Sep 17, 2024
BASE PERIOD IGF::OT::IGF
Department of Defense · $4,402,389 · Oct 31, 2016
NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS
Department of Defense · $3,498,014 · Sep 28, 2022
HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)
Department of Defense · $2,758,080 · Dec 10, 2018
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids